Hydrocolloid Dressings for Oculofacial Wound Healing

This study is looking at how well a special bandage, called a hydrocolloid dressing (DuoDERM EXTRA THIN), works for healing wounds after eye and face surgery (oculofacial reconstruction), especially after a type of skin cancer surgery called Mohs micrographic surgery. The dressing would be put on right after surgery and taken off about a week later. The goal is to see if this dressing can replace antibiotic ointment and make post-surgery care easier for you. We are looking for 20 adults, aged 18 to 100, who can attend follow-up appointments. The main thing we'll be checking is how many people have their wound open up (wound dehiscence) after 3 months. The current status of this study is unclear.

Study design
This is an interventional study, meaning participants will receive a specific treatment. It plans to enroll 20 participants.
What's involved
You would need to attend follow-up appointments at 1 week, 6 weeks, and 3 months in an office setting. The dressing would be applied once after surgery and removed at your 1-week appointment.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 3 months after treatment to check for wound dehiscence.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07075159

Hydrocolloid Dressings for Oculofacial Plastic and Reconstructive Wound Healing

Recruiting
NAAges 18+InterventionalSupportive care
Janice Hernandez, MD
~20 participants
Updated 2025-12-17 on ClinicalTrials.gov
What's tested:Hydrocolloid Wound Dressing

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of participants with wound dehiscence
Measured over 3 months
Wound Healing
Mohs Micrographic Surgery
Oculofacial Reconstruction
1 sites across 1 states
Kentucky1
  • Janice Hernandez, MD · PRINCIPAL_INVESTIGATOR · University of Kentucky

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Patients \>18 years of age
follow-up at specified intervals (1 week/6 week/3 months) in an office setting
can give informed consent
no patients will be excluded on the basis of gender, ethnicity, or religious background

Exclusion

Patients \<18 years of age or \>100
allergy to pectin, gelatin, and sodium carboxymethylcellulose
adults with impaired consent capacity
incarcerated individuals.
  • Number of participants with wound dehiscence3 months

    YES/NO type question if wound dehiscence is present after removal of the patch